Oxford Cannabinoid Technologies Holdings (OCTP) – the company developing prescription cannabinoid medicines – is expanding its research and development plans into oncology. The decision comes…
For those of us who use sophisticated digital tools every day, it’s easy to assume that technology always makes life easier. It doesn’t. https://www.fiercepharma.com/sponsored/build-more-participant-focused-trial-amplify-patient-voice-clinical-research-technology
TauRx Pharmaceuticals – a company focused on Alzheimer’s disease (AD) research – has announced results from its pivotal phase 3 LUCIDITY trial. The study measured…